Welcome & Introduction

Segmentectony Versus Wedge Resection for Stage Non-Small Cell Lung Cancer A Meta analysis

Role of SBRT in Early Stage NSCLC

Newer Paradigms in treatment of resected EGFRm early Lung Cancer

First-generation EGFR-TKIs as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations

141P Chemotherapy with or without Immunotherapy or bevacizumab for EGFR-mutated lung cancer after progression on Osimertinib

Making Critical Decisions in The Treatment of EGFRm NSCLC

Panel discussion - Immunotherapy in stage 3 NSCLC

Closing Remarks